New York Life Investment Management’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,485
Closed -$546K 1344
2023
Q4
$546K Sell
35,485
-900
-2% -$12.5K 0.01% 801
2023
Q3
$458K Sell
36,385
-5,799
-14% -$69.5K 0.01% 797
2023
Q2
$432K Sell
42,184
-6,519
-13% -$64.3K ﹤0.01% 878
2023
Q1
$476K Sell
48,703
-12,756
-21% -$125K 0.01% 993
2022
Q4
$552K Buy
61,459
+6,927
+13% +$55.5K 0.01% 848
2022
Q3
$350K Buy
54,532
+4,008
+8% +$30.5K ﹤0.01% 1035
2022
Q2
$418K Buy
+50,524
New +$463K ﹤0.01% 899

Other funds holding AROC

New York Life Investment Management's AROC Position: Q1 2024 in Review

New York Life Investment Management sold out of Archrock (AROC) in Q1 2024, closing a stake of 35,485 shares — an estimated $546K sold.

New York Life Investment Management first reported a position in AROC in Q2 2022 and held it in 7 quarters. The position peaked at $552K in Q4 2022. 275 funds tracked by Wall St. Rank hold AROC as of Q1 2024.

  • New York Life Investment Management reported no remaining Archrock position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 35,485 Archrock shares in Q1 2024, an estimated $546K.
  • New York Life Investment Management first reported a position in Archrock in Q2 2022 and held it in 7 quarters.
  • New York Life Investment Management's Archrock position peaked at $552K in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Archrock as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.